Gene · 2643
Papers2,670
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,670
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multimodal characterization of transcriptionally defined ventral tegmental area dopamine neurons. | bioRxiv | 2026 | 41889899 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Salinomycin as a death switch: how gastric cancer cells choose their demise. | Cell Death Discov | 2026 | 41876479 | PubTator, text mining | PubMed |
| The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification. | PLoS One | 2026 | 41875089 | PubTator, text mining | PubMed |
| Inflammation-Related alterations in tyrosine metabolism are associated with anhedonia and reduced motivation in Obesity: Influence of Early-Life adversity. | Brain Behav Immun | 2026 | 41833755 | PubTator, text mining | PubMed |
| Targeting the NSUN2-DHODH axis reverses ferroptosis resistance and oxaliplatin resistance in colorectal cancer. | Front Pharmacol | 2026 | 41808866 | PubTator, text mining | PubMed |
| Plasmodium falciparum GTP-cyclohydrolase 1 (Pfgch1) Gene Copy Number Variation and Its Implications in antimalarial resistance from Northeast India. | J Vector Borne Dis | 2026 | 41808336 | PubTator, text mining | PubMed |
| Genetic Adaptation to Tibetan High Altitude and Hepatocellular Cancer Risk: Integrative Bidirectional Mendelian Randomization and Single-Cell RNA Sequencing Analysis. | High Alt Med Biol | 2026 | 41805369 | PubTator, text mining | PubMed |
| Ferroptosis in Parkinson's disease: a review of molecular mechanisms and emerging therapeutic strategies. | Front Neurosci | 2026 | 41799880 | PubTator, text mining | PubMed |
| The role of ferroptosis in osteoporosis: a cellular perspective on osteoblast, osteoclast and osteocyte dysfunction. | Front Endocrinol (Lausanne) | 2026 | 41798188 | PubTator, text mining | PubMed |
| Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target. | Mol Biomed | 2026 | 41795043 | PubTator, text mining | PubMed |
| RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process. | Histol Histopathol | 2026 | 41789593 | PubTator, text mining | PubMed |
| Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugs. | Pharm Sci Adv | 2026 | 41782615 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Zinc finger proteins (ZFPs) in health and disease. | Mol Biomed | 2026 | 41772312 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Essential tremor: Family-based sequencing suggests involvement of neuronal and metabolic pathways. | Parkinsonism Relat Disord | 2026 | 41762786 | PubTator, text mining | PubMed |
| Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulation. | Front Immunol | 2026 | 41756268 | PubTator, text mining | PubMed |
| Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | 41754792 | PubTator, text mining | PubMed |
| A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. | Nutrients | 2026 | 41754196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2643/papers?page=3